# A2A Pharma

> Agent-to-Agent (A2A) + Model Context Protocol (MCP) gateway for pharma.

The global pharma gateway on the A2A Peptides estate.

AI agents for authorized trading partners. Not marketing. Not advertising.

Operator: GreenCore Solutions Corp. · Surface: https://a2a-pharma.ai · version 0.1.2 · as of 2026-09-17 · estate hub https://a2a-peptides.ai

## What it is

A credentialed front door for marketing-authorisation holders onto the A2A Peptides MCP door: the same twenty tools, records and gate, entered as authorized_trading_partner / manufacturer. No second door, no second data set.

## Resources

- https://a2a-pharma.ai/ — The gate page: what it is, your presentations, claim
- https://a2a-pharma.ai/index.md — Markdown twin
- https://a2a-pharma.ai/.well-known/agent-card.json — signed A2A Agent Card; actor preset authorized_trading_partner / manufacturer
- https://a2a-pharma.ai/.well-known/jwks.json — the estate keyring, kid a2ap-2026-09
- https://a2a-pharma.ai/llms.txt — guide for language models
- https://mcp.a2a-peptides.ai/mcp — the A2A Peptides MCP door — the gate's only door
- https://a2a-pharma.ai/health.json — surface status

## Claim

- https://a2a-pharma.ai/#claim — claim your presentations (a person reads the form; no workflow runs on the wire yet)

Notice: Artificial intelligence makes mistakes. A2A Peptides is an information source, not a recommendation. Rules differ by jurisdiction — refer to the regulator in your jurisdiction for the information that applies to you. Regulators (root pages): FDA https://www.fda.gov/ · Health Canada https://www.canada.ca/en/health-canada.html · COFEPRIS https://www.gob.mx/cofepris · EMA https://www.ema.europa.eu/ · MHRA https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency · MFDS https://www.mfds.go.kr/ · PMDA https://www.pmda.go.jp/ · HSA https://www.hsa.gov.sg/ · Swissmedic https://www.swissmedic.ch/